Emergency Use Listing

WHO's advisory group to meet on 26 Oct to decide on EUL for Covaxin says chief scientist Soumya Swaminathan

The approval for the vaccine is much awaited, especially by students, medical tourists, business travellers and people with international travel plans and has been in the works since July.

WHO assessing Covaxin data for EUL, decision on date 'to be confirmed'

WHO on Covaxin: The Bharat Biotech vaccine has demonstrated 77.8% effectiveness against symptomatic COVID-19 and 65.2% protection against the B.1.617.2 Delta variant

Explained: Why WHO's emergency usage listing is important for Bharat Biotech's COVAXIN

The European Union (EU), United Kingdom (UK) and Canada have not included COVAXIN in their approved list of vaccines as it has not been approved by the WHO

Bharat Biotech and WHO to have pre-submission meeting on 23 June to gain Emergency Use Listing

The External Affairs Ministry is coordinating with Bharat Biotech to secure WHO recognition for COVAXIN.